Towards Healthcare Research & Consulting
Oral Solid Dosage Contract Manufacturing Market
Updated Date: 14 July 2026   |   Report Code: 6605
[email protected] +1 804-441-9344
Download Sample Order Now

Oral Solid Dosage Contract Manufacturing Market Industry Forecast 2035

According to Rohan Patil, who specializes in tablet contract manufacturing softgel manufacturing services, and generic drug manufacturing, with 5+ years of experience in market research and industry analysis, extensive research indicates strong growth opportunities in the oral solid dosage contract manufacturing market. The global oral solid dosage contract manufacturing market size was estimated at USD 41.08 billion in 2025 and is predicted to increase from USD 43.65 billion in 2026 to approximately USD 75.26 billion by 2035, expanding at a CAGR of 6.24% from 2026 to 2035. His analysis highlights the increasing adoption of contract development and manufacturing organization services, outsourced oral solid dosage manufacturing, high-volume generic drug production, and formulation development and technology transfer services. The research also examines the competitive strategies of key industry participants, including Lonza, Aenova Group, Recipharm AB, Piramel Pharma, and AbbVie Contract Manufacturing, shaping the future by expanding continuous pharmaceutical manufacturing, advancing smart and autoimmune, strengthening end-to-end CDMO services capabilities, and accelerating development of complex oral solid dosage formulations in the global oral solid dosage contract manufacturing market.

Last Updated : 14 July 2026 Category: Pharmaceuticals Insight Code: 6605 Format: PDF / PPT / Excel

Content

Chapter 1: Introduction

  • Market Definition & Taxonomy
  • Research Objectives
  • Market Scope & Assumptions
  • Study Timeline (Historical, Base Year, Forecast Period)
  • Key Stakeholders Covered

Chapter 2: Research Methodology

  • Research Framework Overview
  • Market Size Estimation Methodology
    • Bottom-Up Approach
    • Top-Down Approach
  • Forecasting Model
    • Dependent Variables
    • Independent Variables
    • Key Assumptions & Weightages
  • Primary Research Insights
  • Secondary Data Sources
  • Data Validation & Triangulation

Chapter 3: Executive Summary

  • Global & Regional Overview (Value, CAGR)
  • Epidemiology Snapshot
  • Segmental Overview
  • Competition Key Snippets
  • Strategic Takeaways

Chapter 4: Market Catalysts, Constraints & Growth Levers

  • Market Dynamics
  • Market Drivers/Catalysts
    • Driver 1
    • Driver 2
  • Market Restraints
    • Restraint 1
    • Restraint 2
  • Market Opportunities
    • Opportunity 1
    • Opportunity 2
  • Market Trends
    • Trend 1
    • Trend 2
  • Impact Assessment of Drivers, Restraints, Opportunities & Trends (High, Mid, & Low)

Chapter 5: Value Added Intelligence

  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers: Low/Moderate/High
    • Bargaining Power of Buyers: Low/Moderate/High
    • Threat of New Entrants: Low/Moderate/High
    • Threat of Substitute: Low/Moderate/High
    • Competitive Rivalry: Low/Moderate/High
  • PESTEL Analysis
  • Ecosystem Analysis
  • Mapping of Key Players
  • Value Chain Analysis
  • Margin Analysis Across Value Chain
  • Macro & Micro Factors Impacting Market
  • Market Potential Evaluation, By Region
  • Epidemiology & Patient Pool Analysis
    • Disease Incidence & Prevalence
    • Target Patient Pool
      • Diagnosed Population
      • Service-Seeking Population
    • Patient Flow & Utilization Analysis
      • Patient Footfall
      • Admission Rates
      • Procedure Volume
    • Healthcare Infrastructure Analysis
      • Number of Facilities
        • Hospitals
        • Clinics
        • Diagnostic Centers
        • ASCs
      • Bed Capacity
        • Total Beds
        • ICU Beds
      • Facility Distribution
    • Operational Metrics Analysis
      • Bed Occupancy Rate (%)
      • Average Length of Stay (ALOS)
    • Service Pricing & Revenue Model
      • Pricing Analysis
        • Cost per Procedure
        • Cost per Consultation
        • Cost per Diagnostic Test
      • Revenue Streams
        • Inpatient Services
        • Outpatient Services
        • Ancillary Services
      • Workforce & Staffing Analysis
        • Healthcare Workforce
          • Physicians
          • Nurses
          • Technicians
        • Staff-to-Patient Ratios
        • Skill Gap Analysis
        • Labor Cost Structure
      • Scenario Analysis (Base / Optimistic / Pessimistic)
      • Risk Assessment & Sensitivity Analysis
      • Opportunity Analysis, By Region
      • Regulatory Analysis
      • Sustainability & ESG Insights
      • Business Models
      • Investment & Funding Landscape
      • Key Conferences and Events

Chapter 7: Segmental & Regional Analysis

  • Global Oral Solid Dosage Contract Manufacturing Market Analysis, By Product
    • Market Size, Forecast & CAGR, By Product, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • Global Oral Solid Dosage Contract Manufacturing Market Analysis, By Mechanism
    • Market Size, Forecast & CAGR, By Product, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • Global Oral Solid Dosage Contract Manufacturing Market Analysis, By End Use
    • Market Size, Forecast & CAGR, By Product, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • Global Oral Solid Dosage Contract Manufacturing Market Analysis, By Region
    • Market Size, Forecast & CAGR, By Product, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • North America Oral Solid Dosage Contract Manufacturing Market Analysis
  • North America Oral Solid Dosage Contract Manufacturing Market Analysis, By Product, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • North America Oral Solid Dosage Contract Manufacturing Market Analysis, By Mechanism, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • North America Oral Solid Dosage Contract Manufacturing Market Analysis, By End Use, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • North America Oral Solid Dosage Contract Manufacturing Market Analysis, By Country, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
      • U. S. Oral Solid Dosage Contract Manufacturing Market Analysis
    • U. S. Oral Solid Dosage Contract Manufacturing Market Analysis, By Product, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
    • U. S. Oral Solid Dosage Contract Manufacturing Market Analysis, By Mechanism, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
    • U. S. Oral Solid Dosage Contract Manufacturing Market Analysis, By End Use, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis

Similar Analysis will be given for each country and each region

  • Canada
  • Mexico
  • Rest of North America

Europe

  • Western Europe
  • Germany
  • Italy
  • France
  • Spain
  • UK
  • Netherlands
  • Switzerland
  • Nordic Countries
  • Rest of Western Europe
  • Eastern Europe
  • Austria
  • Russia & Belarus
  • Poland
  • Türkiye
  • Rest of Eastern Europe

Asia Pacific

  • China
  • Taiwan
  • India
  • Japan
  • Vietnam
  • Australia and New Zealand
  • ASEAN Countries
  • South Korea
  • Rest of APAC

South America

  • Brazil
  • Argentina
  • Rest of South America

Middle East and Africa (MEA)

  • GCC Countries
  • South Africa
  • Egypt
  • Rest of MEA

Chapter 6: Competitive Insights

  • Competitive Analysis
    • Company Evaluation Matrix
      • Major Players
      • Mid-Sized Companies
      • Emerging Players/Start-Ups
    • Global Market Share Analysis, By Region, 2025 (%)
    • Key Player Positioning
    • Competitive Benchmarking
      • By Segment 1
      • By Segment 2
      • By Segment 3
    • Strategies of Key Players
    • Insight From the Horse’s Mouth
  • Company Profiles
    • Catalent Inc.
      • Company Name
      • Company Headquarters
      • Management Overview
        • Key C-Suite Executives
          • CEO
          • MD
          • Others
        • Employee Count
        • Business Strategy
          • Key Investments Made
          • Future Plans
          • R&D & Innovation Capabilities
          • Recent Developments
            • New Product Launch
            • Merger & Acquisitions
            • Partnerships & Collaborations
            • Market Expansion
            • Others
          • Service Portfolio
          • Facility Network
            • Number of Facilities
            • Bed Capacity
            • Facility Distribution
            • Expansion Pipeline
          • Key Financials (2022-2025)
            • Revenue By Segment
            • Revenue By Service
            • Revenue By Geography
            • Financial Matrix (Gross Profit Margins, Net Margins, etc.)
          • Key Clients
            • Client Company Name
            • Key Contact Person
            • Contact Details
          • Regulatory & Certification Expertise
          • SWOT Analysis
    • Lonza
    • Aenova Group
    • Boehringer Ingelheim International GmbH
    • Jubilant Pharmova Limited
    • Patheon Pharma Services
    • Recipharm AB.
    • Corden Pharma International
    • Piramal Pharma Solutions
    • AbbVie Contract Manufacturing

FAQ's

Answer : The oral solid dosage contract manufacturing market currently in 2026 records USD 43.65 billion and is anticipated to grow to USD 75.26 billion by 2035, advancing at a CAGR of 6.24% from 2026 to 2035.

Answer : Asia Pacific is currently leading the oral solid dosage contract manufacturing market due to the reduced manufacturing and operational expenditures, especially in China and India. 

Answer : Major players include Catalent, Lonza, Aenova Group, Boehringer Ingelheim, Jubilant Pharmova, Patheon Pharma Services, Recipharm, Corden Pharma, Piramal Pharma Solutions, and AbbVie Contract Manufacturing, offering comprehensive OSD development and production services.
Any Questions

Meet the Team

Rohan Patil is a seasoned market research professional with over 5+ years of focused experience in the healthcare sector, bringing deep domain expertise, strategic foresight, and analytical precision to every project he undertakes.

Learn more about Rohan Patil

Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.

Learn more about Aditi Shivarkar